Tafamidis for treating transthyretin amyloidosis with cardiomyopathy

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 4.93 MB)

  Published:

  19 June 2024

• Final draft guidance committee papers (PDF 1.11 MB)

  Published:

  19 June 2024